The Peptide Fad: Caveat Emptor

The peptide gray market is already here. The FDA is just catching up.

A group of peptides could be a step closer to becoming available through certain pharmacies after key FDA committee votes last week.

The Peptide Fad: Caveat Emptor

I’m a bit slow when it comes to learning about popular culture and ‘wellness’ fads. But a drive-time piece from NPR this week about this peptide wellness fad captured my attention. Does the science of peptides live up to the hype? In the piece I learned FDA was having advisory committee hearings this week to recommend whether the FDA should legitimize the current ‘gray market’ for untested & unlicensed peptides by officially putting the drugs on…